Home › Pancreatic Diseases › NCT05474417
The Effects of the CF Carrier State on the Kidneys and Pancreas
Who can join
Ages 18 to 100 · All sexes
Full eligibility criteria
CF Carrier Inclusion Criteria: * A CF Carrier identified via genetic testing Control Inclusion Criteria: * No previous CF carrier test results Exclusion Criteria: * CF patient status * Unable to speak English * Currently pregnant * Unable to provide written informed consent * Prisoner status * Currently taking any medications for the treatment of diabetes
About the study
The overarching hypothesis is that CF carriers are at increased risk for developing most of the extrapulmonary conditions associated with CF compared to the general population. Specifically, it is hypothesized that this pilot data will detect subclinical evidence of pancreatic and kidney disorders among CF carriers. This will be determined by bringing CF carriers and controls to the CRU for one visit where they will answer survey questions and undergo laboratory testing. Additionally, they will collect urine and stool samples at home that will be sent to outside laboratories for testing.
Sponsor: Philip Polgreen · Participants: 1,250 · Started: Dec 20, 2021
Contact the study team
- Philip M Polgreen, MD · Phone: (319) 384-6194
- Shelby L Francis, PhD · Phone: 319-678-8037
Official record on ClinicalTrials.gov — NCT05474417
Locations in the U.S.
| Iowa | University of Iowa Hospitals and Clinics, Iowa City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.